Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zibotentan + FOLFIRI in Metastatic Colorectal Cancer
NCT01205711Phase 2Completed
- Sponsor
- Cardiff University
- Start
- Apr 2010
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in colorectal cancer (CRC) comparing FOLFIRI + Placebo with FOLFIRI + Zibotentan (2 arms). Primary endpoint: Progression-Free Survival. Started Apr 2010; status: completed.
02
Drugs
zibotentan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01205711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01205711.